Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 173

1.

PO-14 - Tumour expression of coagulation proteases of the aPC pathway - a role in the pathogenesis of gynaecological cancers?

Martin F, Long JC, O'Toole SA, O'Leary JJ, Abu Saadeh F, Gleeson N, Norris LA.

Thromb Res. 2016 Apr;140 Suppl 1:S181. doi: 10.1016/S0049-3848(16)30147-5. Epub 2016 Apr 8.

PMID:
27161702
2.

Pluripotency markers are differentially induced by MEK inhibition in thyroid and melanoma BRAFV600E cell lines.

Dorris ER, Blackshields G, Sommerville G, Alhashemi M, Dias A, McEneaney V, Smyth P, O'Leary JJ, Sheils O.

Cancer Biol Ther. 2016 May 3;17(5):526-42. doi: 10.1080/15384047.2016.1139230. Epub 2016 Feb 1.

PMID:
26828826
3.

Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening.

O'Mahony JF, Naber SK, Normand C, Sharp L, O'Leary JJ, de Kok IM.

Value Health. 2015 Dec;18(8):1138-51. doi: 10.1016/j.jval.2015.09.2939. Epub 2015 Nov 17. Review.

PMID:
26686801
4.

Endosomal gene expression: a new indicator for prostate cancer patient prognosis?

Johnson IR, Parkinson-Lawrence EJ, Keegan H, Spillane CD, Barry-O'Crowley J, Watson WR, Selemidis S, Butler LM, O'Leary JJ, Brooks DA.

Oncotarget. 2015 Nov 10;6(35):37919-29. doi: 10.18632/oncotarget.6114.

5.

Trends in, and predictors of, anxiety and specific worries following colposcopy: a 12-month longitudinal study.

O'Connor M, O'Leary E, Waller J, Gallagher P, D'arcy T, Flannelly G, Martin CM, McRae J, Prendiville W, Ruttle C, White C, Pilkington L, O'Leary JJ, Sharp L; Irish Cervical Screening Research Consortium (CERVIVA).

Psychooncology. 2016 May;25(5):597-604. doi: 10.1002/pon.3980. Epub 2015 Sep 22.

PMID:
26392040
6.

Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.

McEvoy LM, O'Toole SA, Spillane CD, Martin CM, Gallagher MF, Stordal B, Blackshields G, Sheils O, O'Leary JJ.

BMC Cancer. 2015 Jul 25;15:547. doi: 10.1186/s12885-015-1539-8.

7.

Understanding Women's Differing Experiences of Distress after Colposcopy: A Qualitative Interview Study.

O'Connor M, Waller J, Gallagher P, Martin CM, O'Leary JJ, D'Arcy T, Prendiville W, Flannelly G, Sharp L; Irish Screening Research Consortium (CERVIVA).

Womens Health Issues. 2015 Sep-Oct;25(5):528-34. doi: 10.1016/j.whi.2015.05.009. Epub 2015 Jul 17.

PMID:
26189936
8.

Non-invasive and non-destructive measurements of confluence in cultured adherent cell lines.

Busschots S, O'Toole S, O'Leary JJ, Stordal B.

MethodsX. 2014 Nov 25;2:8-13. doi: 10.1016/j.mex.2014.11.002. eCollection 2015.

9.

Adverse psychological outcomes following colposcopy and related procedures: a systematic review.

O'Connor M, Gallagher P, Waller J, Martin CM, O'Leary JJ, Sharp L; Irish Cervical Screening Research Consortium (CERVIVA).

BJOG. 2016 Jan;123(1):24-38. doi: 10.1111/1471-0528.13462. Epub 2015 Jun 22. Review.

PMID:
26099164
10.

Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones.

Gallagher MF, Salley Y, Spillane CD, Ffrench B, El Baruni S, Blacksheilds G, Smyth P, Martin C, Sheils O, Watson W, O'Leary JJ.

J Clin Pathol. 2015 Sep;68(9):692-702. doi: 10.1136/jclinpath-2015-203001. Epub 2015 Jun 2.

PMID:
26038242
11.

Carboplatin and taxol resistance develops more rapidly in functional BRCA1 compared to dysfunctional BRCA1 ovarian cancer cells.

Busschots S, O'Toole S, O'Leary JJ, Stordal B.

Exp Cell Res. 2015 Aug 1;336(1):1-14. doi: 10.1016/j.yexcr.2014.12.001. Epub 2014 Dec 12.

PMID:
25499884
12.

Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention.

Ffrench B, Gasch C, O'Leary JJ, Gallagher MF.

Mol Cancer. 2014 Dec 11;13:262. doi: 10.1186/1476-4598-13-262. Review.

13.

Raman microspectroscopy for the early detection of pre-malignant changes in cervical tissue.

Rashid N, Nawaz H, Poon KW, Bonnier F, Bakhiet S, Martin C, O'Leary JJ, Byrne HJ, Lyng FM.

Exp Mol Pathol. 2014 Dec;97(3):554-64. doi: 10.1016/j.yexmp.2014.10.013. Epub 2014 Nov 3.

PMID:
25445502
14.

The use of MYBL2 as a novel candidate biomarker of cervical cancer.

Martin CM, Astbury K, Kehoe L, O'Crowley JB, O'Toole S, O'Leary JJ.

Methods Mol Biol. 2015;1249:241-51. doi: 10.1007/978-1-4939-2013-6_18.

PMID:
25348311
15.

Human papillomavirus DNA and mRNA prevalence and association with cervical cytological abnormalities in the Irish HIV population.

Loy A, McInerney J, Pilkington L, Keegan H, Delamere S, Martin CM, Sheils O, O'Leary JJ, Mulcahy F.

Int J STD AIDS. 2015 Oct;26(11):789-95. doi: 10.1177/0956462414553454. Epub 2014 Sep 25.

PMID:
25258395
16.

Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology.

O'Connor M, Costello L, Murphy J, Prendiville W, Martin CM, O'Leary JJ, Sharp L; Irish Screening Research Consortium (CERVIVA).

J Fam Plann Reprod Health Care. 2015 Apr;41(2):134-41. doi: 10.1136/jfprhc-2013-100750. Epub 2014 Sep 23.

PMID:
25248873
17.

An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.

Vencken SF, Sethupathy P, Blackshields G, Spillane C, Elbaruni S, Sheils O, Gallagher MF, O'Leary JJ.

BMC Genomics. 2014 Aug 25;15:711. doi: 10.1186/1471-2164-15-711.

18.

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

d'Adhemar CJ, Spillane CD, Gallagher MF, Bates M, Costello KM, Barry-O'Crowley J, Haley K, Kernan N, Murphy C, Smyth PC, O'Byrne K, Pennington S, Cooke AA, Ffrench B, Martin CM, O'Donnell D, Hennessy B, Stordal B, Finn S, McCann A, Gleeson N, D'Arcy T, Flood B, O'Neill LA, Sheils O, O'Toole S, O'Leary JJ.

PLoS One. 2014 Jun 30;9(6):e100816. doi: 10.1371/journal.pone.0100816. eCollection 2014. Erratum in: PLoS One. 2014;9(9):e108833.

19.

Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.

Woods R Sr, O'Regan EM, Kennedy S, Martin C, O'Leary JJ, Timon C.

World J Clin Cases. 2014 Jun 16;2(6):172-93. doi: 10.12998/wjcc.v2.i6.172. Review.

20.

PARP Inhibitors as P-glyoprotein Substrates.

Lawlor D, Martin P, Busschots S, Thery J, O'Leary JJ, Hennessy BT, Stordal B.

J Pharm Sci. 2014 Jun;103(6):1913-20. doi: 10.1002/jps.23952. Epub 2014 Apr 3.

PMID:
24700236
Items per page

Supplemental Content

Loading ...
Write to the Help Desk